Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Jain

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of the Neurological Sciences|July 8, 2014
Endothelin-1: a potential pathological factor in Parkinson's disease?--From endoplasmic reticulum stress to beyondArjun Jain
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2013
Endothelin-1-induced endoplasmic reticulum stress in diseaseArjun Jain
Reproductive Biomedicine Online|September 22, 2012
Endothelin-1: a key pathological factor in pre-eclampsia?Arjun Jain
Drug Discovery Today|September 24, 2023
ET-traps: Potential therapeutics for preeclampsiaArjun Jain, Ira Jain
Drug Discovery Today|April 24, 2020
ET-traps offer a potential therapeutic tool for use in different autoimmune diseasesArjun Jain, Martin H Johnson
Cellular Reprogramming|June 9, 2025
Precision Reprogramming-Restoring Function to Aged CellsArjun Jain, Yuuki Hosokawa, Kevin Joseph
JAMA Network Open|January 5, 2024
Telehealth Expansion, Internet Speed, and Primary Care Access Before and During COVID-19Alyssa Shell Tilhou, Arjun Jain, Thomas DeLeire
Drug Discovery Today|August 9, 2019
Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?Arjun Jain, Charles Coffey, Vidhi Mehrotra, et al.
Journal of Diabetes and Metabolic Disorders|March 29, 2019
Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetesArjun Jain, Shali Chen, Hannah Yong, et al.
Journal of Diabetes and Metabolic Disorders|July 6, 2019
In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetesArjun Jain, Vidhi Mehrotra, Ira Jha, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of the Neurological Sciences|July 8, 2014
Endothelin-1: a potential pathological factor in Parkinson's disease?--From endoplasmic reticulum stress to beyondArjun Jain
The Journal of Pharmacology and Experimental Therapeutics|June 7, 2013
Endothelin-1-induced endoplasmic reticulum stress in diseaseArjun Jain
Reproductive Biomedicine Online|September 22, 2012
Endothelin-1: a key pathological factor in pre-eclampsia?Arjun Jain
Drug Discovery Today|September 24, 2023
ET-traps: Potential therapeutics for preeclampsiaArjun Jain, Ira Jain
Drug Discovery Today|April 24, 2020
ET-traps offer a potential therapeutic tool for use in different autoimmune diseasesArjun Jain, Martin H Johnson
Cellular Reprogramming|June 9, 2025
Precision Reprogramming-Restoring Function to Aged CellsArjun Jain, Yuuki Hosokawa, Kevin Joseph
JAMA Network Open|January 5, 2024
Telehealth Expansion, Internet Speed, and Primary Care Access Before and During COVID-19Alyssa Shell Tilhou, Arjun Jain, Thomas DeLeire
Drug Discovery Today|August 9, 2019
Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?Arjun Jain, Charles Coffey, Vidhi Mehrotra, et al.
Journal of Diabetes and Metabolic Disorders|March 29, 2019
Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetesArjun Jain, Shali Chen, Hannah Yong, et al.
Journal of Diabetes and Metabolic Disorders|July 6, 2019
In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetesArjun Jain, Vidhi Mehrotra, Ira Jha, et al.
Pageof 2